Phase 1 studies of Walter Reed Army Institute of Research candidate attenuated dengue vaccines: selection of safe and immunogenic monovalent vaccines.

Kanesa-Thasan, N; Edelman, R; Tacket, C O; Wasserman, S S; Vaughn, D W; Coster, T S; Kim-Ahn, G J; Dubois, D R; Putnak, J R; King, A; Summers, P L; Innis, B L; Eckels, K H; Hoke, C H

Kanesa-Thasan, N; Edelman, R; Tacket, C O; Wasserman, S S; Vaughn, D W; Coster, T S; Kim-Ahn, G J; Dubois, D R; Putnak, J R; King, A; Summers, P L; Innis, B L; Eckels, K H; Hoke, C H.

Affiliation

Kanesa-Thasan N; Walter Reed Army Institute of Research, Washington, District of Columbia, USA. niranjan.kanesa-thasan@det.amedd.army.mil

Am J Trop Med Hyg ; 69(6 Suppl): 17-23, 2003 Dec.

Article de En | MEDLINE | ID: mdl-14740951

Sujet(s)

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links

Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins antiviraux / Dengue / Virus de la dengue / Anticorps antiviraux Type d'étude: Clinical_trials Limites: Adolescent / Adult / Female / Humans / Male / Middle aged Pays/Région comme sujet: America do norte Langue: En Journal: Am J Trop Med Hyg Année: 2003 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Recherche sur Google

Ajouter à My VHL

Imprimer

XML

PubMed Links